Probi AB (OSTO:PROB) Additional Paid-In Capital : kr600.2 Mil(As of Mar. 2024)

View and export this data going back to 1998. Start your Free Trial

What is Probi AB Additional Paid-In Capital?

Probi AB's quarterly additional paid-in capital stayed the same from Sep. 2023 (kr600.2 Mil) to Dec. 2023 (kr600.2 Mil) and stayed the same from Dec. 2023 (kr600.2 Mil) to Mar. 2024 (kr600.2 Mil).

Probi AB's annual additional paid-in capital stayed the same from Dec. 2021 (kr600.2 Mil) to Dec. 2022 (kr600.2 Mil) and stayed the same from Dec. 2022 (kr600.2 Mil) to Dec. 2023 (kr600.2 Mil).

Probi AB Additional Paid-In Capital Historical Data

The historical data trend for Probi AB's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Probi AB Additional Paid-In Capital Chart

Probi AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

Get a 7-Day Free Trial

600.21

Probi AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Additional Paid-In Capital	Get a 7-Day Free Trial															600.21	600.21	600.21	600.21	600.21

Probi AB Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Probi AB Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Probi AB's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Probi AB (OSTO:PROB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Probi AB (OSTO:PROB) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

PBBIF:USA

Address

Ideongatan 1 A, Lund, SWE, SE-223 70

Website

https://www.probi.com

Probi AB is engaged in probiotic research and development, manufacturing and sales of effective and well-documented probiotics. The company's research relates to living microorganisms with scientific health benefits. The main fields of research are gut health, immune system and nutrient absorption, iron absorption, bone health and stress and recovery. It operates in Consumer Healthcare (CHC) and Functional Food (FF). The company operates in United States, Americas, excluding the United States , Sweden, EMEA, excluding Sweden, and APAC. The company's business is divided into three operating segments. These segments are based on a geographical division and consist of the regions Americas (North and South America), EMEA (Europe, Middle East and Africa) and APAC (Asia and the Pacific).

Probi AB (OSTO:PROB) Headlines

No Headlines